Verity Asset Management, Inc. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q4 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verity Asset Management, Inc. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$693,000
+8.1%
3,540
-6.1%
0.53%
-10.8%
Q2 2020$641,000
+31.4%
3,771
-10.8%
0.59%
-3.9%
Q1 2020$488,000
-15.3%
4,229
-16.1%
0.62%
+7.3%
Q4 2019$576,000
+9.9%
5,039
-17.9%
0.57%
+4.4%
Q3 2019$524,000
+1.7%
6,139
-17.5%
0.55%
-5.0%
Q2 2019$515,000
+4.0%
7,439
+10.2%
0.58%
+0.9%
Q1 2019$495,000
+36.4%
6,753
+5.4%
0.57%
+17.9%
Q4 2018$363,000
-9.7%
6,408
+22.8%
0.49%
+22.4%
Q3 2018$402,000
+3.1%
5,218
-11.1%
0.40%
+13.1%
Q2 2018$390,000
+35.4%
5,871
+6.5%
0.35%
+34.0%
Q1 2018$288,000
+8.3%
5,511
+8.3%
0.26%
+31.0%
Q4 2017$266,000
-25.3%
5,090
-12.3%
0.20%
-26.2%
Q3 2017$356,000
+17.1%
5,804
-1.3%
0.27%
+18.9%
Q2 2017$304,000
+7.8%
5,882
+31.0%
0.23%
-2.1%
Q1 2017$282,000
+31.8%
4,491
-5.7%
0.23%
-5.3%
Q4 2015$214,000
+4.9%
4,760
-10.0%
0.25%
+20.6%
Q3 2015$204,000
-25.5%
5,286
-6.7%
0.20%
-17.7%
Q2 2015$274,000
+19.7%
5,663
-20.6%
0.25%
+12.2%
Q4 2014$229,000
+1.3%
7,132
+20.6%
0.22%
-10.2%
Q2 2014$226,000
-16.6%
5,912
+2.1%
0.25%
-11.5%
Q1 2014$271,0000.0%5,792
-14.7%
0.28%
-6.1%
Q4 2013$271,0006,7940.30%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders